NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $51,024,000 | -83.0% | 692,794 | -67.0% | 1.11% | -79.0% |
| Q4 2021 | $300,131,000 | -31.0% | 2,097,794 | 0.0% | 5.29% | -12.2% |
| Q3 2021 | $434,894,000 | -20.0% | 2,097,794 | -18.1% | 6.03% | -30.9% |
| Q2 2021 | $543,496,000 | -0.1% | 2,559,918 | -14.7% | 8.72% | +6.3% |
| Q1 2021 | $544,308,000 | +28.8% | 3,002,087 | -20.8% | 8.21% | +39.0% |
| Q4 2020 | $422,463,000 | +225.3% | 3,788,564 | +216.1% | 5.91% | +148.7% |
| Q3 2020 | $129,869,000 | -67.3% | 1,198,602 | -74.8% | 2.38% | -69.3% |
| Q2 2020 | $396,649,000 | – | 4,758,833 | – | 7.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |